Adult’s hypothyroidism: progress in diagnosis and treatment

doi:10.3969/j.issn.1004-583X.2016.03.008

Abstract

Abstract: Hypothyroidism is a common disease in endocrinology, clinical hypothyroidism requires active treatment, under certain circumstances, subclinical hypothyroidism also needs intervention. Replacement therapy of levothyroxine sodium is a major countermeasure,while certaindrugs and foods may affect its absorption or use, taking method should have more attention. As the new treatment is constantly exploring,with the accumulation of evidence-based medicine, clinical treatment method will be improved gradually.

Key words: atrialfibrillation, radiofrequencycatheterablation, hypothyroidism, thyroxine, therapy

CLC Number:

R581.2

Meng Fengling. Adult’s hypothyroidism: progress in diagnosis and treatment[J]. Clinical Focus, 2016, 31(3): 262-267.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.03.008

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I3/262

References

[1] Mansourian AR. A review on the metabolic disorders of iodine deficiency[J]. Pak J Biol Sci,2011,14(7): 412-424.
[2] Fiore E, Tonacchera M, Vitti P. Influence of iodization programmes on the epidemiology of nodular goitre[J]. Best Pract Res Clin Endocrinol Metab,2014,28(4): 577-588.
[3] Thomson CD, Campbell JM, Miller J, et al. Minimal impact of excess iodate intake on thyroid hormones and selenium status in older New Zealanders[J]. Eur J Endocrinol,2011,165(5): 745-752.
[4] Kaneshige T, Arata N, Harada S, et al. Changes in serum iodine concentration, urinary iodine excretion and thyroid function after hysterosalpingography using an oil-soluble iodinated contrast medium (lipiodol)[J]. J Clin Endocrinol Metab,2015,100(3): E469-472.
[5] Cooper DS,Biondi B. Subclinical thyroid disease[J]. Lancet,2012,379(9821):1142-1154.
[6] Eastman CJ. Screening for thyroid disease and iodine deficiency[J]. Pathology,2012,44(2): 153-159.
[7] Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association[J]. Thyroid,2012,22(12): 1200-1235.
[8] Sijbom M, van Lieshout J, Felix-Schollaart B, et al. Summary of the 'Thyroid disorders' guideline of the Dutch College of General Practitioners' (NHG) [J]. Ned Tijdschr Geneeskd, 2013,157(35): A6667.
[9] Sukumar R, Agarwal A, Gupta S, et al. Prediction of LT4 replacement dose to achieve euthyroidism in subjects undergoing total thyroidectomy for benign thyroid disorders[J]. World J Surg,2010,34(3): 527-531.
[10] Devdhar M, Drooger R, Pehlivanova M, et al. Levothyroxine replacement doses are affected by gender and weight, but not age[J]. Thyroid,2011,21(8): 821-827.
[11] Hoang TD, Olsen CH, Mai VQ, et al. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study[J]. J Clin Endocrinol Metab,2013,98(5): 1982-1990.
[12] 王可可. 口服左甲状腺素钠需要注意的问题[J]. 药品评价,2014,11(3): 42-45.
[13] Vita R, Saraceno G, Trimarchi F, et al. A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations[J]. Endocrine,2013, 43(1): 154-160.
[14] Abi-Abib RC, Vaisman M. Is it necessary to increase the dose of levothyroxine in patients with hypothyroidism who use omeprazole?[J]. Arq Bras Endocrinol Metabol,2014,58(7): 731-736.
[15] Cellini M, Santaguida MG, Gatto I, et al. Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine[J]. J Clin Endocrinol Metab,2014,99(8): E1454-1458.
[16] Bolk N, Visser TJ, Nijman J, et al. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial[J]. Arch Intern Med,2010,170(22): 1996-2003.
[17] Wiersinga WM, Duntas L, Fadeyev V, et al. 2012 ETA Guidelines: the Use of L-T4 + L-T3 in the treatment of hypothyroidism[J]. Eur Thyroid J,2012, 1(2): 55-71.
[18] Wartofsky L. Combination L-T3 and L-T4 therapy for hypothyroidism[J]. Curr Opin Endocrinol Diabetes Obes,2013,20(5): 460-466.
[19] Biondi B, Wartofsky L. Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism[J]. J Clin Endocrinol Metab,2012, 97(7): 2256-2271.
[20] Solter D, Solter M. Benefit of combined triiodothyronine (LT(3)) and thyroxine (LT(4)) treatment in athyreotic patients unresponsive to LT(4) alone[J]. Exp Clin Endocrinol Diabetes,2012,120(2): 121-123.
[21] Celi FS, Zemskova M, Linderman JD, et al. The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients[J]. Clin Endocrinol (Oxf),2010,72(5): 709-715.
[22] Celi FS, Zemskova M, Linderman JD, et al. Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine[J]. J Clin Endocrinol Metab,2011,96(11): 3466-3474.
[23] Fadeyev VV, Morgunova TB, Melnichenko GA, et al.Combined therapy with L-thyroxine and L-triiodothyronine compared to L-thyroxine alone in the treatment of primary hypothyroidism[J]. Hormones (Athens),2010,9(3): 245-252.
[24] Shakoor SK, Aldibbiat A, Ingoe LE, et al. Endothelial progenitor cells in subclinical hypothyroidism: the effect of thyroid hormone replacement therapy[J]. J Clin Endocrinol Metab,2010,95(1): 319-322.
[25] Wiersinga WM. Cardiovascular risks in patients with subclinical thyroid dysfunction [J]. Ned Tijdschr Geneeskd,2012,156(49): A5477.
[26] Hofling DB, Chavantes MC, Juliano AG, et al. Low-level laser in the treatment of patients with hypothyroidism induced by chronic autoimmune thyroiditis: a randomized, placebo-controlled clinical trial[J]. Lasers Med Sci,2013,28(3): 743-753.
[27] Hofling DB, Chavantes MC, Juliano AG, et al. Low-level laser therapy in chronic autoimmune thyroiditis: a pilot study[J]. Lasers Surg Med,2010,42(6): 589-596.
[28] Singh P, Singh B, Dave R, et al.The impact of yoga upon female patients suffering from hypothyroidism[J]. Complement Ther Clin Pract,2011,17(3): 132-134.
[29] Cornelli U, Belcaro G, Ledda A, et al. Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism[J]. Panminerva Med,2011,53(3 Suppl 1): 99-103.
[30] Bornschein A, Paz-Filho G, Graf H, et al. Treating primary hypothyroidism with weekly doses of levothyroxine: a randomized, single-blind, crossover study[J]. Arq Bras Endocrinol Metabol,2012,56(4): 250-258.